Oscar Health, Inc. (NYSE:OSCR) Receives Consensus Rating of “Hold” from Analysts

Shares of Oscar Health, Inc. (NYSE:OSCR) have earned a consensus recommendation of “Hold” from the twelve analysts that are covering the company, MarketBeat reports. One analyst has rated the stock with a sell recommendation, eight have given a hold recommendation and three have issued a buy recommendation on the company. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $20.7778.

Several research firms have weighed in on OSCR. Wells Fargo & Company set a $20.00 target price on Oscar Health and gave the company an “equal weight” rating in a research note on Thursday, June 4th. Wolfe Research started coverage on Oscar Health in a research note on Tuesday, May 5th. They issued a “peer perform” rating on the stock. UBS Group raised their price target on Oscar Health from $15.00 to $20.00 and gave the stock a “neutral” rating in a research report on Thursday, May 7th. Zacks Research lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a research report on Friday, June 5th. Finally, Jefferies Financial Group raised Oscar Health from an “underperform” rating to a “hold” rating and raised their price target for the stock from $10.00 to $16.00 in a research report on Monday, April 20th.

Insider Activity at Oscar Health

In other news, CAO Victoria Baltrus sold 1,523 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total transaction of $33,414.62. Following the sale, the chief accounting officer owned 214,589 shares of the company’s stock, valued at $4,708,082.66. This trade represents a 0.70% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Mario Schlosser sold 34,120 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $21.94, for a total value of $748,592.80. Following the sale, the director directly owned 480,866 shares in the company, valued at approximately $10,550,200.04. This represents a 6.63% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold a total of 189,660 shares of company stock valued at $4,283,140 over the last 90 days. Insiders own 24.39% of the company’s stock.

Institutional Investors Weigh In On Oscar Health

A number of hedge funds have recently modified their holdings of OSCR. Thrive Capital Management LLC raised its position in Oscar Health by 33.4% in the 4th quarter. Thrive Capital Management LLC now owns 6,343,617 shares of the company’s stock valued at $85,258,000 after buying an additional 1,588,395 shares during the last quarter. Baird Financial Group Inc. acquired a new stake in Oscar Health in the 1st quarter valued at approximately $159,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its position in Oscar Health by 4.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 215,650 shares of the company’s stock valued at $2,827,000 after buying an additional 8,879 shares during the last quarter. Jones Financial Companies Lllp raised its position in Oscar Health by 7,473.3% in the 1st quarter. Jones Financial Companies Lllp now owns 2,272 shares of the company’s stock valued at $30,000 after buying an additional 2,242 shares during the last quarter. Finally, UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its position in Oscar Health by 39.0% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 470,590 shares of the company’s stock valued at $6,169,000 after buying an additional 132,149 shares during the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.

Oscar Health Trading Down 0.1%

NYSE:OSCR opened at $28.37 on Friday. Oscar Health has a 1-year low of $10.69 and a 1-year high of $29.81. The business’s 50-day moving average price is $21.61 and its two-hundred day moving average price is $16.93. The company has a current ratio of 1.11, a quick ratio of 1.11 and a debt-to-equity ratio of 0.26. The firm has a market capitalization of $8.55 billion, a price-to-earnings ratio of -48.09, a PEG ratio of 1.99 and a beta of 2.37.

Oscar Health (NYSE:OSCR) last released its earnings results on Wednesday, May 6th. The company reported $2.07 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.96. Oscar Health had a negative return on equity of 3.26% and a negative net margin of 0.30%.The firm had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.90 billion. During the same quarter in the prior year, the firm posted $0.92 earnings per share. The company’s quarterly revenue was up 52.6% on a year-over-year basis. On average, equities analysts expect that Oscar Health will post 0.47 earnings per share for the current year.

About Oscar Health

Oscar Health, trading on the New York Stock Exchange under the ticker OSCR, is a technology-driven health insurance company headquartered in New York, New York. Founded in 2012 by Mario Schlosser, Joshua Kushner and Kevin Nazemi, the company was built with the goal of simplifying healthcare coverage and enhancing member experience. Oscar leverages a proprietary digital platform to streamline plan enrollment, claims administration and member support, distinguishing itself in the individual, family and small group insurance markets.

The company’s primary products include on-exchange individual and family medical plans under the Affordable Care Act, off-exchange plans, as well as Medicare Advantage offerings.